title: Revisiting the role of raphe and serotonin in neuropsychiatric disorders.
authors.affiliation: Institute of Biomedicine and Biotechnology of Cantabria, IBBTEC (CSIC, Universidad de Cantabria), 39011 Santander, Spain albert.adell@unican.es.
authors.forename: Albert
authors.initials: A
authors.lastname: Adell
mesh_terms: D000200:Action Potentials; D000818:Animals; D005089:Exocytosis; D008297:Male; D059326:Serotonergic Neurons / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism*
chemical_list: D012701:Serotonin
references.citation: Br J Pharmacol. 1989 May;97(1):206-12
references.pmid: 2720308
references.citation: J Neurosci. 1998 Sep 15;18(18):7394-401
references.pmid: 9736659
references.citation: J Comp Neurol. 2015 Jul 1;523(10):1488-504
references.pmid: 25652113
references.citation: Brain Res Brain Res Rev. 2002 Sep;39(2-3):154-80
references.pmid: 12423765
references.citation: Neuropsychopharmacology. 2004 Oct;29(10):1800-6
references.pmid: 15127086
references.citation: Science. 1976 Feb 6;191(4226):478-80
references.pmid: 1246632
references.citation: Biol Psychiatry. 1987 Dec;22(12):1429-38
references.pmid: 3676370
references.citation: J Neurochem. 1989 Jul;53(1):234-40
references.pmid: 2470860
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1991 Mar;343(3):237-44
references.pmid: 1714040
references.citation: Brain Res. 1992 Jul 3;584(1-2):322-4
references.pmid: 1515949
references.citation: J Neurosci. 1996 Apr 15;16(8):2820-8
references.pmid: 8786456
references.citation: J Neural Transm (Vienna). 1996;103(1-2):173-90
references.pmid: 9026372
references.citation: Trends Neurosci. 1996 Sep;19(9):378-83
references.pmid: 8873352
references.citation: Br J Pharmacol. 1997 Aug;121(8):1707-15
references.pmid: 9283707
references.citation: J Comp Neurol. 2000 Feb 7;417(2):181-94
references.pmid: 10660896
references.citation: Biol Psychiatry. 1999 Jul 15;46(2):212-20
references.pmid: 10418696
references.citation: Pharmacol Rev. 1999 Sep;51(3):533-91
references.pmid: 10471417
references.citation: Mol Psychiatry. 2009 Jun;14(6):621-30
references.pmid: 18268499
references.citation: Brain Res. 2009 Jul 24;1281:35-46
references.pmid: 19446538
references.citation: Biol Psychiatry. 2010 Jan 15;67(2):117-24
references.pmid: 19819426
references.citation: Neuron. 2010 Jan 14;65(1):40-52
references.pmid: 20152112
references.citation: J Neurosci. 2010 Dec 1;30(48):16082-90
references.pmid: 21123555
references.citation: Mol Psychiatry. 2012 Jun;17(6):612-23
references.pmid: 21808255
references.citation: J Neurosci. 2012 Nov 7;32(45):15737-46
references.pmid: 23136413
references.citation: Nature. 2012 Dec 20;492(7429):428-32
references.pmid: 23160494
references.citation: Psychopharmacology (Berl). 2013 Jul;228(1):157-66
references.pmid: 23455595
references.citation: J Gen Physiol. 2015 Mar;145(3):225-51
references.pmid: 25712017
references.citation: Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2557-62
references.pmid: 25675490